Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

1.1 List of Tables
1.2 List of Figures

2.1 Continuous Glucose Monitoring Systems Overview

3.1 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
3.2 Continuous Glucose Monitoring Systems - Pipeline Products by Territory
3.3 Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
3.4 Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
3.5 Continuous Glucose Monitoring Systems - Ongoing Clinical Trials

4.1 Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development

5.1 A. Menarini Diagnostics Srl Company Overview
5.2 Abbott Diabetes Care Inc Company Overview
5.3 Advanced Biosensors-Ohio LLC (Inactive) Company Overview
5.4 Advanced Medical Electronics Corp Company Overview
5.5 Arkal Medical, Inc. (Inactive) Company Overview
5.6 Ascensia Diabetes Care Holdings AG Company Overview
5.7 Azurite Technologies, Inc. (Inactive) Company Overview
5.8 Biorasis Inc Company Overview
5.9 Biovotion AG Company Overview
5.10 Brigham and Women's Hospital Company Overview
5.11 CALISTO MEDICAL, INC. (Inactive) Company Overview
5.12 CGM3 Ltd Company Overview
5.13 City, University of London Company Overview
5.14 Columbia University Company Overview
5.15 ConvaTec Group Plc Company Overview
5.16 Cyber Medical Ltd Company Overview
5.17 Debiotech SA Company Overview
5.18 DexCom Inc Company Overview
5.19 DirectSens GmbH Company Overview
5.20 Echo Therapeutics Inc Company Overview
5.21 Ecole Polytechnique Federale de Lausanne Company Overview
5.22 eLutions Integrated Systems, Inc. Company Overview
5.23 EyeSense GmbH Company Overview
5.24 Flowsion A/S Company Overview
5.25 Gili Medical Ltd Company Overview
5.26 Globe Medical Tech Inc (Inactive) Company Overview
5.27 GlucoLight Corporation (Inactive) Company Overview
5.28 Glucometrix AG Company Overview
5.29 Glucosense Diagnostics Ltd (Inactive) Company Overview
5.30 GlucoSet AS Company Overview
5.31 Glucovation Inc Company Overview
5.32 GluMetrics Inc Company Overview
5.33 Glusense Ltd Company Overview
5.34 GlySens Inc Company Overview
5.35 G-Sense Ltd. Company Overview
5.36 iGlyko, Inc. (Inactive) Company Overview
5.37 Indigo Diabetes NV Company Overview
5.38 Innovosens AB Company Overview
5.39 Insulet Corp Company Overview
5.40 Integrated Medical Sensors Company Overview
5.41 Integrity Applications Ltd Company Overview
5.42 Invivosense ASA (Inactive) Company Overview
5.43 I-Sens Inc Company Overview
5.44 iSense Corporation (Inactive) Company Overview
5.45 Keratin Biosciences Inc Company Overview
5.46 Know Labs Inc Company Overview
5.47 KTH Royal Institute of Technology Company Overview
5.48 LEMM Technologies, LLC Company Overview
5.49 Massachusetts Institute of Technology Company Overview
5.50 Medical Wireless Sensing Ltd Company Overview
5.51 Medtronic Diabetes Company Overview
5.52 Medtronic plc Company Overview
5.53 Mellitor Ltd Company Overview
5.54 Metronom Health Inc Company Overview
5.55 mobiLIFE Company Overview
5.56 Nemaura Medical Inc Company Overview
5.57 Newton Photonics Inc Company Overview
5.58 Northwestern University Company Overview
5.59 Orsus Medical Ltd Company Overview
5.60 PKvitality Company Overview
5.61 PositiveID Corp Company Overview
5.62 Prediktor Medical AS Company Overview
5.63 Profusa Inc Company Overview
5.64 Purdue University Company Overview
5.65 San Meditech (Huzhou) Co., Ltd. Company Overview
5.66 Senseonics Holdings Inc Company Overview
5.67 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
5.68 Senzime AB Company Overview
5.69 Singapore Biomicro Pte Ltd Company Overview
5.70 Socrates Health Solutions, Inc. Company Overview
5.71 Stony Brook University Company Overview
5.72 Swansea University Company Overview
5.73 Tenax Therapeutics Inc Company Overview
5.74 Terumo Corp Company Overview
5.75 Texas A&M University Company Overview
5.76 Ultradian Diagnostics LLC Company Overview
5.77 University of California Berkeley Company Overview
5.78 University of California Irvine Company Overview
5.79 University of California San Diego Company Overview
5.80 University of South Carolina Company Overview
5.81 University of South Florida Company Overview
5.82 University of Technology Sydney Company Overview
5.83 University of Texas at Arlington Company Overview
5.84 VeriTeQ Corporation Company Overview
5.85 Vytrace, Inc. Company Overview
5.86 WaveForm Technologies Inc Company Overview
5.87 Zyvex Corp Company Overview

6.1 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
6.2 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
6.3 Jul 18, 2019: Nemaura Medical appoints Chris Avery as vice president of global business operations to support global commercial launch of SugarBEAT
6.4 Jul 17, 2019: Know Labs announces significant pre-clinical progress of uband non-invasive continuous glucose monitor
6.5 Jul 10, 2019: Nemaura Medical submits de novo 510(k) application for SugarBEAT to the U.S. Food and Drug Administration
6.6 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility
6.7 Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps
6.8 Jun 25, 2019: ConvaTec Group: Board Change
6.9 Jun 18, 2019: Senzime contracts new CFO
6.10 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update
6.11 Jun 17, 2019: Abbott reports second-quarter 2019 results
6.12 Jun 11, 2019: Abbott’s FreeStyle device helps significantly reduce glucose levels
6.13 Jun 10, 2019: Real-World data from Guardian Connect and Sugar.IQ reveal improved diabetes outcomes
6.14 Jun 08, 2019: Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes
6.15 Jun 08, 2019: Medtronic initiates pivotal trial for next-generation Guardian Continuous Glucose Monitoring Sensor
6.16 Jun 07, 2019: Senzime's board member Ulf Lindskog has passed away
6.17 Jun 06, 2019: Senseonics announces FDA approval for a non-adjunctive indication (Dosing Claim) for the Eversense 90-day CGM System
6.18 Jun 05, 2019: Senseonics to present real-world, long-term safety data of the First Implantable CGM Sensor at the American Diabetes Association’s 79th Scientific Sessions
6.19 Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency

7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
Table 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
Table 6: Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
Table 7: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Table 8: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 9: GlucoMen Day - Product Status
Table 10: GlucoMen Day - Product Description
Table 11: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 13: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 14: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status
Table 15: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description
Table 16: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - A Comparative Study on the Accuracy and Usability Between the Dexcom G5 Mobile CGM System and the FreeStyle Flash Glucose Monitoring System
Table 18: FreeStyle Libre Flash Glucose Monitoring System - Children - An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System
Table 19: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Table 20: FreeStyle Libre Flash Glucose Monitoring System - Children - Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents with Type 1 Diabetes: A Carowanis Camp Study
Table 21: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - Prediction and Prevention of Nocturnal Hypoglycemia in Persons with Type 1 Diabetes with Multiple Doses of Insulin using Machine Learning Techniques
Table 23: Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 24: My Medibit - Product Status
Table 25: My Medibit - Product Description
Table 26: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Continuous Glucose Monitor - Product Status
Table 28: Continuous Glucose Monitor - Product Description
Table 29: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: GlucoPod CGM System - Product Status
Table 31: GlucoPod CGM System - Product Description
Table 32: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
Table 33: CONTOUR PLUS ONE - Product Status
Table 34: CONTOUR PLUS ONE - Product Description
Table 35: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Blood Glucose Sensor - Product Status
Table 37: Blood Glucose Sensor - Product Description
Table 38: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Glucowizzard - Product Status
Table 40: Glucowizzard - Product Description
Table 41: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
Table 42: VSM 3 Glucose Monitoring System - Product Status
Table 43: VSM 3 Glucose Monitoring System - Product Description
Table 44: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Fluorescence Measurement Device - Product Status
Table 46: Fluorescence Measurement Device - Product Description
Table 47: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Glucoband - Product Status
Table 49: Glucoband - Product Description
Table 50: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview

Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials